CS logo
small CS logo
Jsc Evex Hospitals

Kutaisi, Georgia
7M9G+W5X, მ 15, Kutaisi

About Jsc Evex Hospitals


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
BrainsGate
2
Incyte Corporation
2
Yuria-Pharm
2
Angion Biomedica Corp
1
EirGenix, Inc.
1
Incyte Biosciences International Sàrl
1
Kartos Therapeutics, Inc.
1
Total Rows: 7

Clinical Trials at Jsc Evex Hospitals


During the past decade, Jsc Evex Hospitals conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100330011331100000000000000Started TrialsCompleted Trails201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window
2011-06-01
2018-06-01
Completed
1,078
Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer
2018-10-16
2022-01-20
Completed
807
THE IMPACT- 24M TRIAL (IMPlant Augmenting Cerebral Blood Flow in Mild Strokes Trial 24 Hours From Stroke Onset)
2018-04-02
2018-09-11
Completed
50
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.
2016-12-06
2019-12-11
Completed
180
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Peritonitis
2018-01-10
2019-12-03
Completed
180
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer
2020-09-27
2025-08-01
Recruiting
600
Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.
2021-01-26
2025-06-22
Recruiting
300
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis
2021-04-13
2025-10-01
Recruiting
52

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Jsc Evex Hospitals" #1 sponsor was "BrainsGate" with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Yuria-Pharm" with 2 trials sponsored, "Angion Biomedica Corp" with 1 trials sponsored and "EirGenix, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Jsc Evex Hospitals" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBrainsGate: 2BrainsGate: 2Incyte Corporation: 2Incyte Corporation: 2Yuria-Pharm: 2Yuria-Pharm: 2Angion Biomedica Corp: 1Angion Biomedica Corp: 1EirGenix, Inc.: 1EirGenix, Inc.: 1Incyte BiosciencesInternational Sàrl: 1Incyte BiosciencesInternational Sàrl: 1Kartos Therapeutics, Inc.: 1Kartos Therapeutics, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsEuropean Network ofGynaecologicalOncological Trial Groups(ENGOT): 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1GOG Foundation: 1GOG Foundation: 1Zai Lab (Shanghai) Co., Ltd.: 1Zai Lab (Shanghai) Co., Ltd.: 1

Clinical Trials Conditions at Jsc Evex Hospitals


According to Clinical.Site data, the most researched conditions in "Jsc Evex Hospitals" are "Ischemic Stroke" (2 trials), "Breast Cancer" (1 trials), "Endometrial Cancer" (1 trials), "Glomerular Disease" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Jsc Evex Hospitals" in a lesser frequency.

Clinical Trials Intervention Types at Jsc Evex Hospitals


Most popular intervention types in "Jsc Evex Hospitals" are "Drug" (8 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "INCAGN02385" (2 trials), "INCAGN02390" (2 trials), "Retifanlimab" (2 trials) and "Rheosorbilact®" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Jsc Evex Hospitals


The vast majority of trials in "Jsc Evex Hospitals" are 8 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Jsc Evex Hospitals


Currently, there are NaN active trials in "Jsc Evex Hospitals". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Jsc Evex Hospitals, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Jsc Evex Hospitals, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 4Phase 2: 4Not Applicable: 2Not Applicable: 2Phase 3: 2Phase 3: 2Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Recruiting: 5Recruiting: 5